Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease.

Bossers K, Wirz KT, Meerhoff GF, Essing AH, van Dongen JW, Houba P, Kruse CG, Verhaagen J, Swaab DF.

Brain. 2010 Dec;133(Pt 12):3699-723. doi: 10.1093/brain/awq258. Epub 2010 Oct 1.

PMID:
20889584
2.

Analysis of gene expression in Parkinson's disease: possible involvement of neurotrophic support and axon guidance in dopaminergic cell death.

Bossers K, Meerhoff G, Balesar R, van Dongen JW, Kruse CG, Swaab DF, Verhaagen J.

Brain Pathol. 2009 Jan;19(1):91-107. doi: 10.1111/j.1750-3639.2008.00171.x. Epub 2008 May 7.

PMID:
18462474
3.

Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism.

Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E, Dekker MC, Squitieri F, Ibanez P, Joosse M, van Dongen JW, Vanacore N, van Swieten JC, Brice A, Meco G, van Duijn CM, Oostra BA, Heutink P.

Science. 2003 Jan 10;299(5604):256-9. Epub 2002 Nov 21.

4.

Mutations in TITF-1 are associated with benign hereditary chorea.

Breedveld GJ, van Dongen JW, Danesino C, Guala A, Percy AK, Dure LS, Harper P, Lazarou LP, van der Linde H, Joosse M, Grüters A, MacDonald ME, de Vries BB, Arts WF, Oostra BA, Krude H, Heutink P.

Hum Mol Genet. 2002 Apr 15;11(8):971-9.

PMID:
11971878
5.

Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma.

Dijkstra AT, Majoie IM, van Dongen JW, van Weelden H, van Vloten WA.

J Eur Acad Dermatol Venereol. 2001 Nov;15(6):550-4.

PMID:
11843215
6.

A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis.

Njajou OT, Vaessen N, Joosse M, Berghuis B, van Dongen JW, Breuning MH, Snijders PJ, Rutten WP, Sandkuijl LA, Oostra BA, van Duijn CM, Heutink P.

Nat Genet. 2001 Jul;28(3):213-4.

PMID:
11431687
7.

Coronary artery bypass grafting without cardiopulmonary bypass and without interruption of native coronary flow using a novel anastomosis site restraining device ("Octopus").

Borst C, Jansen EW, Tulleken CA, Gründeman PF, Mansvelt Beck HJ, van Dongen JW, Hodde KC, Bredée JJ.

J Am Coll Cardiol. 1996 May;27(6):1356-64.

8.

Loss and gain of chromosomes 1, 18, and Y in prostate cancer.

König JJ, Teubel W, van Dongen JW, Romijn JC, Hagemeijer A, Schröder FH.

Prostate. 1994 Dec;25(6):281-91.

PMID:
7527913
9.

Preferential loss of abnormal prostate carcinoma cells by collagenase treatment.

König JJ, van Dongen JW, Schröder FH.

Cytometry. 1993 Oct;14(7):805-10.

10.

Tissue culture loss of aneuploid cells from carcinomas of the prostate.

König JJ, Teubel W, van Dongen JW, Hagemeijer A, Romijn JC, Schröder FH.

Genes Chromosomes Cancer. 1993 Sep;8(1):22-7.

PMID:
7691155
11.

Human renal cell carcinoma in the six day subrenal capsule assay.

Weissglas MG, Romijn JC, van Dongen JW, Cappendijk MJ, ten Kate FJ, Kurth KH.

J Urol. 1989 Oct;142(4):1106-9.

PMID:
2795739
12.

The cytocidal effect of high energy shock waves on human prostatic tumour cell lines.

van Dongen JW, van Steenbrugge GJ, Romijn JC, Schröder FH.

Eur J Cancer Clin Oncol. 1989 Aug;25(8):1173-9.

PMID:
2767106
13.

The human prostatic carcinoma cell line LNCaP and its derivatives. An overview.

van Steenbrugge GJ, Groen M, van Dongen JW, Bolt J, van der Korput H, Trapman J, Hasenson M, Horoszewicz J.

Urol Res. 1989;17(2):71-7. Review.

PMID:
2660395
14.

In vivo and in vitro chemotherapy sensitivity testing for human kidney tumor lines: a comparative study.

Kurth KH, Romijn JC, Kappendijk M, Weissglas MG, van Dongen JW.

Semin Surg Oncol. 1988;4(2):103-9.

PMID:
3393774
15.

Arrest of the proliferation of renal and prostate carcinomas of human origin by inhibition of mitochondrial protein synthesis.

van den Bogert C, Dontje BH, Holtrop M, Melis TE, Romijn JC, van Dongen JW, Kroon AM.

Cancer Res. 1986 Jul;46(7):3283-9.

Supplemental Content

Loading ...
Support Center